Table of Contents

Rybelsus is the familiar oral semaglutide product for many patients. In May 2026, Ozempic became available as an oral tablet formulation, called Ozempic tablets. However, Rybelsus and Ozempic tablets are not substitutable on a mg-to-mg basis.

This guide explains the Rybelsus and Ozempic pill dosing schedule, how to take them properly, what to do if you miss a dose, possible side effects by dose, and how Rybelsus compares with the new Ozempic pill.

Medical disclaimer: This article is for informational purposes only and does not replace medical advice from a licensed healthcare provider. Always take Rybelsus or Ozempic tablet exactly as prescribed.

Key Takeaways

  • Rybelsus usually starts at 3 mg once daily for 30 days, then increases to 7 mg once daily. Ozempic tablet starts at 1.5 mg, then increases to 4 mg, then 9 mg.
  • The 3 mg and 1.5 mg doses are starter doses, mainly used to help the body adjust. They’re not intended for full blood sugar control.
  • Rybelsus or Ozempic pill must be taken first thing in the morning, on an empty stomach, with no more than 4 ounces of plain water.
  • Wait at least 30 minutes after taking Rybelsus or Ozempic pill before eating, drinking coffee, taking supplements, or taking other oral medications.
  • With BuyCanadianInsulin, you can get Rybelsus starting at $298 per month, plus a 10% discount with code FIRST10.

What is the dosing schedule for Rybelsus?

The usual Rybelsus dosing schedule is:

Time on treatment Usual dose
Days 1 to 30 3 mg once daily
Days 31 to 60 7 mg once daily
Day 61 and after 14 mg once daily

Do not increase your dose unless your healthcare provider tells you to. Rybelsus doses are not meant to be changed on your own.

Can you start Rybelsus at 7mg?

No. Rybelsus starts at 3 mg to help your body get used to semaglutide. Stomach-related side effects such as nausea, diarrhea, stomach pain, vomiting, and reduced appetite may be more likely when starting or increasing the dose.

The 3 mg dose is not considered a full treatment dose for blood sugar control. It is mainly used as a starting dose before increasing to 7 mg.

When do you increase from Rybelsus 3 mg to 7 mg?

Most people increase to 7 mg after taking Rybelsus 3 mg once daily for 30 days.

The 7 mg dose is the usual first maintenance dose. Your healthcare provider may monitor your blood sugar, A1C, side effects, weight changes, and overall response before deciding whether to keep you at 7 mg or increase later.

When do you increase from Rybelsus 7 mg to 14 mg?

Your healthcare provider may consider increasing the dose after at least 30 days on 7 mg. The decision depends on your treatment goals, blood sugar results, side effects, other medications, and overall health history.

Some people stay on 7 mg once daily. Others may increase to 14 mg once daily if additional blood sugar control is needed.

What is the maximum dose of Rybelsus?

The maximum usual Rybelsus dose is 14 mg once daily.

Do not take more than 14 mg per day unless your healthcare provider gives you specific instructions. Do not take extra tablets to make up for a missed dose.

Can you take two 7 mg Rybelsus tablets instead of one 14 mg tablet?

Do not take two 7 mg tablets to make a 14 mg dose unless your healthcare provider specifically tells you to do so.

Rybelsus should be taken exactly as prescribed. If you are unsure which tablet strength you should be taking, check with your doctor, pharmacist, or prescribing clinic before changing your dose.

Can you take 28 mg of Rybelsus?

No, unless your prescriber specifically directed it. The current Rybelsus label lists 3 mg, 7 mg, and 14 mg tablets, with the recommended escalation to 7 mg, then 14 mg once daily if more glucose control is needed. It also says to take one tablet once daily and not more than one tablet per day.

Researchers investigated higher doses of oral semaglutide and compared once-daily 14 mg vs 25 mg vs 50 mg for 68 weeks in adults with type 2 diabetes. The higher doses worked better than 14 mg:

Oral semaglutide dose HbA1c reduction Weight loss
14 mg 1.5% 4.7%
25 mg 1.8% 7.3%
50 mg 2.0% 8.5%

However, taking two 14 mg Rybelsus tablets (28 mg) is not the same thing as taking 25 mg or 50 mg oral semaglutide formulations used in trials.

If you’re looking for a higher-dose oral semaglutide option for weight loss, Wegovy tablets may be a better fit, which is available as a 25 mg once-daily dose. In its trial in adults with overweight or obesity without diabetes, the 25 mg dose led to about 14% weight loss vs 2% with placebo at week 64.

What is the dosing schedule for Ozempic tablets?

Rybelsus and Ozempic tablets are not substitutable on a mg-to-mg basis. Here’s how their dosing schedules differ:

Time on treatment Rybelsus Ozempic tablets
Days 1 to 30 3 mg once daily 1.5 mg once daily
Days 31 to 60 7 mg once daily 4 mg once daily
Day 61 and after 14 mg once daily (highest dose) 9 mg once daily (highest dose)

Can you switch between Rybelsus and Ozempic tablets?

Yes, but this should only be done with your healthcare provider’s guidance.

In general, when switching between Rybelsus and Ozempic tablets, you have to wait until after the first 30 days of treatment. During this initiation phase, your body is still adjusting to semaglutide, and switching too early may increase the risk of gastrointestinal side effects.

Once you’ve completed the first 30 days, you may switch between the two oral semaglutide products using equivalent doses. Simply start the new tablet the day after stopping the previous one.

For example, if you’re taking Rybelsus 7 mg, you can switch to Ozempic tablets 4 mg. If you’re taking Rybelsus 14 mg, you can switch to Ozempic tablets 9 mg.

Can you switch from Ozempic injection to Rybelsus or Ozempic tablets?

Yes, under your healthcare provider’s instructions. In general, you should wait one week after your last 0.5 mg Ozempic injection before switching to oral semaglutide treatment. You may then begin Rybelsus at either 7 mg or 14 mg once daily or Ozempic tablets at either 4 mg or 9 mg once daily.

How to take Rybelsus and Ozempic pills correctly

Oral semaglutide products have specific instructions because food, drinks, and other medications can reduce how much semaglutide your body absorbs.

Follow these steps:

    • Take Rybelsus or Ozempic tablet first thing in the morning.
    • Take it on an empty stomach.
    • Use no more than 4 ounces of plain water.
    • Swallow the tablet whole.
    • Do not split, crush, chew, or dissolve the tablet.
    • Wait at least 30 minutes before eating or drinking.
    • Wait at least 30 minutes before taking other oral medications.

Taking Rybelsus or Ozempic tablet the right way can help the medication work as intended.

What happens if you take oral semaglutide with food?

Taking Rybelsus or Ozempic tablets with food can reduce absorption, which may make it less effective.

A 2021 study showed that people who ate before taking the oral semaglutide tablet had little to no detectable semaglutide in their blood. On the other hand, everyone who fasted had measurable drug levels.

You should also avoid taking Rybelsus or Ozempic tablet with coffee, tea, juice, milk, soda, or any liquid other than plain water. Even drinking too much water with the tablet can affect absorption.

For best results, take Rybelsus or Ozempic tablet with a small amount of plain water, then wait at least 30 minutes before breakfast, coffee, supplements, or other oral medications.

Can you drink coffee after taking Rybelsus or Ozempic tablet?

Yes, but you should wait at least 30 minutes before drinking coffee. This includes black coffee. Even though black coffee has few or no calories, Rybelsus or Ozempic tablet should only be taken with plain water.

Is it better to take oral semaglutide in the morning or at night?

Rybelsus or Ozempic tablet is generally taken in the morning because it must be taken on an empty stomach before food, drinks, and other oral medications. Night dosing may be difficult because your stomach may not be fully empty.

Can you take Rybelsus or Ozempic tablet with metformin?

Yes. They’re commonly used with metformin in adults with type 2 diabetes. However, Rybelsus or Ozempic tablet should be taken first, then wait at least 30 minutes before taking metformin.

A common routine looks like this:

    1. Take Rybelsus or Ozempic tablet immediately after waking.
    2. Wait at least 30 minutes.
    3. Eat breakfast.
    4. Take metformin with breakfast if your doctor says to take it with food.

Metformin is often taken with meals to reduce stomach upset. If you take metformin more than once daily, later doses are usually taken with other meals.

If your prescription label gives different timing instructions, follow the label.

What happens if you miss a dose of Rybelsus or Ozempic tablet?

If you miss a dose, skip the missed dose and take your next dose the following day. Do not take an extra tablet later in the day to make up for the missed dose.

Bottom line

Rybelsus dosing usually starts with 3 mg once daily for 30 days, followed by 7 mg once daily. If additional blood sugar control is needed, a healthcare provider may increase the dose to 14 mg once daily. Ozempic pill follows a similar structure but starts at 1.5 mg, increasing to 4 mg, then to its maximum dose, 9 mg.

Taking Rybelsus or Ozempic pill as directed is important to ensure it works properly. Take them in the morning on an empty stomach with no more than 4 ounces of plain water, then wait at least 30 minutes before eating, drinking, or taking other oral medications.

If you have questions about your dose, side effects, weight loss goals, or switching from another GLP-1 medication, speak with your healthcare provider before making any changes.

Frequently Asked Questions

No. Rybelsus 7 mg is not considered equivalent to Ozempic injection because oral and injectable semaglutide are absorbed differently and are not converted milligram-for-milligram.
Both contain semaglutide and can cause similar risks, such as nausea, vomiting, diarrhea, pancreatitis, gallbladder problems, low blood sugar when used with insulin or sulfonylureas, and a boxed warning about thyroid C-cell tumors. The safer choice depends on your medical history, dose, side effects, and how well you tolerate tablets versus injections.
No, not for weight loss. Rybelsus is mainly used for type 2 diabetes, while Wegovy is specifically approved for weight management and is available in higher-dose semaglutide options, including a 25 mg oral tablet. Because they are different products, they should not be compared or switched without medical guidance.
Both can cause stomach-related side effects, including nausea, vomiting, diarrhea, constipation, and abdominal pain. Some people may tolerate one better than the other, but there is no guarantee that Rybelsus will be gentler than Ozempic.
Avoid taking Rybelsus with food, coffee, juice, or other medications right away, because this can reduce absorption. Take it with no more than 4 ounces of plain water, swallow it whole, and wait at least 30 minutes before eating, drinking, or taking other oral medicines. Do not split, crush, chew, or take more than one tablet per day unless your prescriber tells you otherwise.
Taking too much Rybelsus may increase the risk of side effects such as nausea, vomiting, diarrhea, dehydration, low blood sugar if used with certain diabetes medicines, and other complications. Because semaglutide stays in the body for about a week, symptoms may need monitoring for an extended period. Contact a healthcare professional or Poison Help (1-800-222-1222) right away if an overdose is suspected.
Yes, some people may lose weight on Rybelsus 7 mg. In clinical trials of adults with type 2 diabetes, people taking Rybelsus 7 mg once daily lost about 2.2 to 2.4 kg (~5 lbs) over 26 weeks. In one monotherapy trial, average weight loss was 2.3 kg with Rybelsus 7 mg compared with 1.4 kg with placebo. In another trial involving people taking metformin alone or metformin with a sulfonylurea, average weight loss was 2.2 kg with Rybelsus 7 mg compared with 0.6 kg with sitagliptin. Weight loss results vary significantly between individuals.

Sources

Wharton, S., Lingvay, I., Bogdanski, P., Vale, R. D. D., Jacob, S., Karlsson, T., Shaji, C., Rubino, D., & Garvey, W. T. (2025). Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine, 393(11), 1077–1087. https://doi.org/10.1056/nejmoa2500969

Aroda, V. R., Aberle, J., Bardtrum, L., Christiansen, E., Knop, F. K., Gabery, S., Pedersen, S. D., & Buse, J. B. (2023). Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial. The Lancet, 402(10403), 693–704. https://doi.org/10.1016/s0140-6736(23)01127-3

Bækdal, T. A., Breitschaft, A., Donsmark, M., Maarbjerg, S. J., Søndergaard, F. L., & Borregaard, J. (2021). Effect of various dosing conditions on the pharmacokinetics of oral semaglutide, a human Glucagon-Like peptide-1 analogue in a tablet formulation. Diabetes Therapy, 12(7), 1915–1927. https://doi.org/10.1007/s13300-021-01078-y

HIGHLIGHTS OF PRESCRIBING INFORMATION OF RYBELSUS. https://www.novo-pi.com/rybelsus.pdf

PR Newswire. (2026). Novo Nordisk’s Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US. https://www.prnewswire.com/news-releases/novo-nordisks-ozempic-pill-the-only-fda-approved-oral-peptide-glp-1-medication-for-adults-with-type-2-diabetes-soon-to-be-available-in-the-us-302760106.html

Kenneth Fill, PharmD, MBA

Kenneth Fill, PharmD, MBA, is a clinical pharmacist specialist and medical writer with a strong background in ambulatory care, pharmacogenomics, and medical content development. Based in the state of Michigan, he provides expert guidance on chronic disease state management. Kenneth completed his PharmD and MBA at the University of Toledo and pursued post-graduate residency training in ambulatory care and community-based pharmacy. His diverse background also includes academic detailing, clinical education, and interdisciplinary collaboration to enhance patient outcomes.